JBG Cos

Jubilant Bhartia Group is a global conglomerate with a significant presence in the life sciences sector through its key subsidiaries, Jubilant Pharmova and Jubilant Ingrevia. The company operates across the entire pharmaceutical value chain, providing services in drug discovery and development (Jubilant Biosys), contract manufacturing of sterile injectables (Jubilant HollisterStier), and the production of radiopharmaceuticals and allergy immunotherapy products. Its innovative biotech arm, Jubilant Therapeutics, is advancing a pipeline of small molecule inhibitors for oncology and autoimmune diseases, with lead programs targeting LSD1/HDAC6 and PRMT5. With a global footprint and integrated capabilities, Jubilant is a major partner for pharmaceutical companies worldwide, offering both proprietary drug development and comprehensive outsourcing services.